美索巴莫
化合物
美索巴莫(英語:Methocarbamol,商品名:Robaxin等),分子式C11H15NO5,是一種用於短期肌肉骨骼系統疼痛的藥物[3][4]。
臨床資料 | |
---|---|
商品名 | Robaxin, Marbaxin, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682579 |
核准狀況 | |
懷孕分級 |
|
給藥途徑 | By mouth, intravenous |
ATC碼 | |
法律規範狀態 | |
法律規範 |
|
藥物動力學數據 | |
藥物代謝 | Liver |
生物半衰期 | 1.14–1.24 hours[2] |
識別資訊 | |
| |
CAS號 | 532-03-6 |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.007.751 |
化學資訊 | |
化學式 | C11H15NO5 |
摩爾質量 | 241.24 g·mol−1 |
3D模型(JSmol) | |
| |
|
參考文獻
- ^ Robaxin-750 - Summary of Product Characteristics (SmPC). (emc). 8 August 2017 [19 April 2020]. (原始內容存檔於2021-08-29).
- ^ Sica DA, Comstock TJ, Davis J, Manning L, Powell R, Melikian A, Wright G. Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals. European Journal of Clinical Pharmacology. 1990, 39 (2): 193–4. PMID 2253675. S2CID 626920. doi:10.1007/BF00280060.
- ^ Methocarbamol Monograph for Professionals. Drugs.com. American Society of Health-System Pharmacists. [2022-12-11]. (原始內容存檔於2021-03-04).
- ^ British national formulary : BNF 76 76. Pharmaceutical Press. 2018: 1093. ISBN 9780857113382.
外部連結
- Methocarbamol. Drug Information Portal. U.S. National Library of Medicine. [2022-12-11]. (原始內容存檔於2017-01-23).